June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Recombinant VEGF165b inhibits TNF-α-induced ICAM-1 expression and monocyte adhesion in primary human retinal pigment epithelial cells
Author Affiliations & Notes
  • Peeradech Thichanpiang
    Department of Anatomy, Faculty of Science, Mahidol University, Bangkok, Thailand
    Microvascular Research Laboratories, School of Physiology and Pharmacology, University of Bristol, Bristol, United Kingdom
  • David Bates
    Microvascular Research Laboratories, School of Physiology and Pharmacology, University of Bristol, Bristol, United Kingdom
  • Kanokpan Wongprasert
    Department of Anatomy, Faculty of Science, Mahidol University, Bangkok, Thailand
  • Footnotes
    Commercial Relationships Peeradech Thichanpiang, None; David Bates, University of Bristol (P); Kanokpan Wongprasert, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 153. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Peeradech Thichanpiang, David Bates, Kanokpan Wongprasert; Recombinant VEGF165b inhibits TNF-α-induced ICAM-1 expression and monocyte adhesion in primary human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 2013;54(15):153.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Local inflammation at the retinal pigment epithelial (RPE) cell layer is associated with inflammatory cell migration and secretion of pro-inflammatory cytokines such as Tumor necrosis factor (TNF)-α. TNF-α up-regulates Intercellular Cell Adhesion Molecule (ICAM)-1 expression on RPE that allows binding of lymphocyte function-associated antigen-1 (LFA-1) on leukocytes contributing to leukocyte adhesion at sites of inflammation. VEGF165b is generated by alternative splicing of VEGF-A in the terminal exon 8. VEGF165b is cytoprotective and anti-angiogenic but its effects on inflammation have not been elucidated. Therefore, our aim was to investigate the effects of VEGF165b on TNF-α-induced ICAM-1 expression and monocyte adhesion in RPE cells.

 
Methods
 

Primary RPE cells were pretreated with 20 ng/ml TNF-α alone, 100 ng/ml VEGF165b alone, 100 ng/ml VEGF165b with 100 ng/ml anti-VEGF165b, 100 ng/ml VEGF165b or 10 nM ZM323881 (VEGFR2 inhibitor) prior to exposure to 20 ng/ml TNF-α for 24 h. After the experiment, cells were lysed for Western blotting and monocyte adhesion assays were performed.

 
Results
 

VEGF165b and ZM323881 inhibited TNF-α-induced upregulation of ICAM-1 in RPE cells. VEGF165b was neutralized by antibody to VEGF165b (Figure 1). VEGF165b ameliorated the TNF-α-induced monocyte-RPE adhesion (Figure 2).

 
Conclusions
 

These findings indicate that VEGF165b inhibits the TNF-α-mediated upregulation of ICAM-1 expression and increases monocyte-RPE cell adhesion, suggesting an anti-inflammatory property of VEGF165b in the eye.

 
 
Figure 1. Western blotting showing effects of VEGF165b and ZM323881 on TNF-α-induced upregulation of ICAM-1 in RPE cells.
 
Figure 1. Western blotting showing effects of VEGF165b and ZM323881 on TNF-α-induced upregulation of ICAM-1 in RPE cells.
 
 
Figure 2. Decreased adhesion of monocytes to RPE cells after inhibition of ICAM-1 expression by VEGF165b.
 
Figure 2. Decreased adhesion of monocytes to RPE cells after inhibition of ICAM-1 expression by VEGF165b.
 
Keywords: 557 inflammation • 701 retinal pigment epithelium • 748 vascular endothelial growth factor  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×